VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization
Recruiting · NCT05724433 · Interventional (participants receive a specific treatment) · Lead sponsor: Population Health Research Institute
View the official record on ClinicalTrials.gov →Interventions studied
Routine HF CareVirtual HF Care
What this trial is about
The clinic visits (intervention) will continue for 90 days, which represents the follow-up period for the primary medication and health status outcomes. The co-primary clinical outcomes will be obtained at 180 days.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adult patients ≥ 18 years old who:
- Are being discharged after hospitalization or urgent visit for HF as
- a primary diagnosis or
- significant complication (prolonging length of stay) of another diagnosis OR Have been referred for an initial consult at a cardiology clinic within 1 week of hospitalization or urgent visit for HF as a primary or secondary diagnosis, as described above.
- Have left ventricular ejection fraction (LVEF) \< 50% within the preceding 3 months.
- Have NT-proBNP of \> 900 pg/ml during hospital admission or within 7 days after discharge from the ED
- Have a mailing address for patient or caregiver
- Provide verbal consent
Exclusion criteria
- Died or left hospital before medically advised hospital discharge
- Unable to self-assess or communicate symptoms (e.g. clinically evident dementia)
- Unable to engage with digital health technology or follow up
- Severe valve disease
- Recipient of or on waiting list for LVAD or cardiac transplant
- Complex congenital heart disease, hypertrophic obstructive cardiomyopathy, or amyloid cardiomyopathy
- Severe lung disease with symptoms on minimal exertion, forced expiratory volume during 1 second (FEV1) \< 1 litre, severe pulmonary hypertension with RVSP \> 60 mm Hg, or on home oxygen
- Severe kidney disease (persistent eGFR \< 30 mL/min/1.73m2)
- Active malignancy
- Receiving palliative care or expected life expectancy \< 6 months
Where it is running
9 locations listed.
- Fattouma Bourguiba Hospital - Monastir, Tunisia
- Hedi Chaker Hospital - Sfax, Tunisia
- Sahloul Hospital - Sousse, Tunisia
- Military Hospital - Tunis, Tunisia
- St. Joseph's Healthcare Hamilton - Hamilton, Onatrio, Canada
- Hamilton General Hospital - Hamilton, Ontario, Canada
- Juravinski Hospital Cancer Centre - Hamilton, Ontario, Canada
- Thunder Bay Regional Health Sciences Centre - Thunder Bay, Ontario, Canada
- Unity Health Toronto - Toronto, Ontario, Canada